Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- anti-bacterial agents 2 Treffer
- antibodies, monoclonal, humanized 2 Treffer
- diabetes mellitus, type 2 2 Treffer
- healthy volunteers 2 Treffer
- neoplasms 2 Treffer
-
36 weitere Werte:
- 1-deoxynojirimycin 1 Treffer
- adenosine a2 receptor antagonists 1 Treffer
- albumins 1 Treffer
- alpha-galactosidase 1 Treffer
- angiogenesis inhibitors 1 Treffer
- antibodies, monoclonal 1 Treffer
- antineoplastic agents, phytogenic 1 Treffer
- antiviral agents 1 Treffer
- boronic acids 1 Treffer
- bridged bicyclo compounds, heterocyclic 1 Treffer
- buprenorphine 1 Treffer
- calcitonin gene-related peptide 1 Treffer
- capsaicin 1 Treffer
- cephalosporins 1 Treffer
- chemokine cxcl10 1 Treffer
- cytochrome p-450 cyp3a inducers 1 Treffer
- cytochrome p-450 cyp3a inhibitors 1 Treffer
- dipeptidyl-peptidase iv inhibitors 1 Treffer
- herpes genitalis 1 Treffer
- herpesvirus 2, human 1 Treffer
- immunosuppressive agents 1 Treffer
- indoles 1 Treffer
- interleukin-17 1 Treffer
- isoenzymes 1 Treffer
- lupus erythematosus, systemic 1 Treffer
- niacinamide 1 Treffer
- nonlinear dynamics 1 Treffer
- oxadiazoles 1 Treffer
- paclitaxel 1 Treffer
- parkinson disease 1 Treffer
- protein kinase inhibitors 1 Treffer
- psoriasis 1 Treffer
- renal insufficiency 1 Treffer
- sodium-glucose transporter 2 inhibitors 1 Treffer
- teicoplanin 1 Treffer
- tetrahydronaphthalenes 1 Treffer
Sprache
Inhaltsanbieter
15 Treffer
-
In: Clinical pharmacology in drug development, Jg. 13 (2024-05-01), Heft 5, S. 549-559Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 13 (2024-05-01), Heft 5, S. 474-484Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-09-01), Heft 9, S. 1064-1074Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-09-01), Heft 9, S. 1075-1088Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-07-01), Heft 7, S. 696-706Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-05-01), Heft 5, S. 440-452Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-04-01), Heft 4, S. 420-427Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021), Heft 1, S. 8-21Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 9 (2020-08-01), Heft 6, S. 689-698Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 9 (2020), Heft 1, S. 21-31Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-06-01), Heft 6, S. 622-633Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 10 (2021-02-01), Heft 2, S. 115-130Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 4 (2015-11-01), Heft 6, S. 463-72Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 3 (2014-09-01), Heft 5, S. 365-70Online academicJournalZugriff:
-
In: Clinical pharmacology in drug development, Jg. 3 (2014-07-01), Heft 4, S. 297-304Online academicJournalZugriff: